Successfully upholding polymer use patent of CROMA-PHARMA GESELLSCHAFT M.B.H.
Recently, the China National Intellectual Property Administration issued a decision of examination of request for invalidation, upholding the validity of a polymer use patent of the CROMA-PHARMA GESELLSCHAFT M.B.H.
The partner Dr. Stephen Zou, the partner Dr. Cao Lili, and attorney Xu Feifei appeared in court to participate the oral trial, and Dr. Zhang Yuan and Mr. Jia Zhaonian provided great support. With full communication with the client and in-depth study of relevant materials, the team members formulated targeted strategies of response, and finally won satisfactory result with their defense opinions being accepted by the collegiate panel.
Pressing the petitioner to withdraw the request for invalidation in a case about the patent of insomnia treatment medicine of an Israeli pharmaceutical company
In an invalidation case against the patent of insomnia treatment medicine of an Israeli pharmaceutical company, the China National Intellectual Property Administration announced the termination of the trial because the petitioner withdrew the request for invalidation.
The partner Dr. Stephen Zou and the partner Dr. Cao Lili were responsible for this case, together with Dr. Tu Tao and Dr. Zhang Yuan as the team members. On the basis of comprehensive study and thorough analysis, the team provided a powerful defense. Finally, the petitioner withdrew the invalidation request after the oral examination.
The client fully affirmed the strength of Liu Shen’s biomedical team, and highly praised the rigorousness, fairness, and efficiency of the patent invalidation examination procedure of China.
Sweeping potential legal risks for a Chinese innovative pharmaceutical company to launch anti-tumor medicines
After unremitting efforts of nearly two years, Liu Shen’s biomedical team swept potential legal risks for a Chinese innovative pharmaceutical company to launch the anti-tumor medicines on market.
The partner Dr. Stephen Zou and the partner Dr. Liu Guojun were responsible for this case, together with Dr. Cao Lili, Dr. Zhang Yuan and Dr. Mou Ke as the team members. After taking the client’s opinions and marketing plan into full consideration, the team formulated an overall targeted strategy including various means such as submission of third party opinions, invalidation procedure, and etc., to promote the two parties to reach a settlement, which swept the potential legal risks for the launch of the product and successfully achieved the set goal of the client.